COMMUNIQUÉS West-GlobeNewswire

InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026
BEIJING, Aug. 18, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
MemoHoney Details Supplement Facts Panel, Serving Directions and Label Information
18/08/2026
Niacin, Calcium, L-Arginine, L-Arginine AKG, L-Citrulline HCl, L-Citrulline Malate and Beta Alanine Combine in a 30-Capsule Memory, Focus and Energy Formula Ogden, UT, Aug. 17, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Functional Brands Announces Second Quarter 2026 Financial Results
17/08/2026
LAKE OSWEGO, Ore., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Functional Brands Inc. (OTC Markets: MEHA), a leading innovator in wellness and performance products, today announced financial results for the second quarter ended [...]
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, [...]
La Fenice Centre Brings Independently Published Frequency Therapy Research to Thornbury
17/08/2026
Co-founder Deanna Pietramala's Brain Science study adds outside validation to the clinic's therapies Thornbury, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Deanna Pietramala, co-founder of La Fenice Centre for Neuro Integrative [...]
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
BRISBANE, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that [...]
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
17/08/2026
Nominating and Governance Chair Carol Burt to become Lead Director. Ron Taylor to retire after more than 21 years of service on Resmed’s Board of Directors. SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD [...]
Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
17/08/2026
LITTLETON, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
FOSTER CITY, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on August 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “ [...]
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
17/08/2026
– Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets – – Completes transformation of Coherus Oncology into a fully integrated, innovative immuno-oncology company – REDWOOD CITY, [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 33 - 2026
17/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 11 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2026
17/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases on 11th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily [...]
MD Logic Health Unveils Innovative Daily Multi-Fiber Supplement Featuring Clinically-Proven Solnul Resistant Potato Starch
17/08/2026
Powered by a robust 4-fiber formulation of both soluble and insoluble fibers to promote natural satiety, metabolic balance, and comfortable regularity. Miami, FLORIDA, Aug. 17, 2026 (GLOBE NEWSWIRE) -- MD Logic Health [...]
Cooper Clinic Introduces Digital Nutrition Platform
17/08/2026
Online nutrition community classes launch September 29 DALLAS , Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cooper Clinic announces the addition of The Learning Plate digital platform to its nutrition services offerings. This [...]
Pharmacy Planet surpasses 200,000 YouTube subscribers and highlights the growth of its healthcare education platform
17/08/2026
How one UK pharmacy is redefining health education by turning expert conversations into content that hundreds of thousands of people actively choose to watch LONDON, Aug. 17, 2026 (GLOBE NEWSWIRE) -- In an age where [...]
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
17/08/2026
DENVER, Aug. 17, 2026 (GLOBE NEWSWIRE) -- There is a tendency to think of a Nasdaq listing as simply a better place for a stock to trade. For NeOnc Technologies Holdings (NASDAQ: NTHI), however, the Nasdaq Global Market [...]
Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies
17/08/2026
The Patent Claims are for the Intended Commercial Formulation of ART27.13 Expected to Extend Patent Protection for ART27.13 through 2041 SOLANA BEACH, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( [...]
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment
17/08/2026
Pluri's majority-owned food-tech company adds aquatic cell biology, animal-component-free media capabilities and a European scientific presence Ever After Foods secures an additional $2 million strategic investment [...]

Pages